BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38096266)

  • 1. Arginine vasopressin regulates the renal Na
    Carbajal-Contreras H; Murillo-de-Ozores AR; Magaña-Avila G; Marquez-Salinas A; Bourqui L; Tellez-Sutterlin M; Bahena-Lopez JP; Cortes-Arroyo E; Behn-Eschenburg SG; Lopez-Saavedra A; Vazquez N; Ellison DH; Loffing J; Gamba G; Castañeda-Bueno M
    Am J Physiol Renal Physiol; 2024 Feb; 326(2):F285-F299. PubMed ID: 38096266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of the WNK4-SPAK/OSR1 pathway has a minor effect on baseline NKCC2 phosphorylation.
    Maeoka Y; Nguyen LT; Sharma A; Cornelius RJ; Su XT; Gutierrez MR; Carbajal-Contreras H; Castañeda-Bueno M; Gamba G; McCormick JA
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F39-F56. PubMed ID: 37881876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
    Ferdaus MZ; Barber KW; López-Cayuqueo KI; Terker AS; Argaiz ER; Gassaway BM; Chambrey R; Gamba G; Rinehart J; McCormick JA
    J Physiol; 2016 Sep; 594(17):4945-66. PubMed ID: 27068441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNK bodies cluster WNK4 and SPAK/OSR1 to promote NCC activation in hypokalemia.
    Thomson MN; Cuevas CA; Bewarder TM; Dittmayer C; Miller LN; Si J; Cornelius RJ; Su XT; Yang CL; McCormick JA; Hadchouel J; Ellison DH; Bachmann S; Mutig K
    Am J Physiol Renal Physiol; 2020 Jan; 318(1):F216-F228. PubMed ID: 31736353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Ste20-related proline/alanine-rich kinase (SPAK)-independent pathway involving calcium-binding protein 39 (Cab39) and serine threonine kinase with no lysine member 4 (WNK4) in the activation of Na-K-Cl cotransporters.
    Ponce-Coria J; Markadieu N; Austin TM; Flammang L; Rios K; Welling PA; Delpire E
    J Biol Chem; 2014 Jun; 289(25):17680-8. PubMed ID: 24811174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
    Argaiz ER; Chavez-Canales M; Ostrosky-Frid M; Rodríguez-Gama A; Vázquez N; Gonzalez-Rodriguez X; Garcia-Valdes J; Hadchouel J; Ellison D; Gamba G
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F734-F745. PubMed ID: 29846116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of NCC activity by low and high K(+) intake: insights into the signaling pathways involved.
    Castañeda-Bueno M; Cervantes-Perez LG; Rojas-Vega L; Arroyo-Garza I; Vázquez N; Moreno E; Gamba G
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1507-19. PubMed ID: 24761002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of WNK4 and SPAK in K
    Mukherjee A; Yang CL; McCormick JA; Martz K; Sharma A; Ellison DH
    Am J Physiol Renal Physiol; 2021 May; 320(5):F719-F733. PubMed ID: 33719576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPAK differentially mediates vasopressin effects on sodium cotransporters.
    Saritas T; Borschewski A; McCormick JA; Paliege A; Dathe C; Uchida S; Terker A; Himmerkus N; Bleich M; Demaretz S; Laghmani K; Delpire E; Ellison DH; Bachmann S; Mutig K
    J Am Soc Nephrol; 2013 Feb; 24(3):407-18. PubMed ID: 23393317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MST3 Involvement in Na
    Chan CH; Wu SN; Bao BY; Li HW; Lu TL
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
    Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
    Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
    PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular K
    Penton D; Czogalla J; Wengi A; Himmerkus N; Loffing-Cueni D; Carrel M; Rajaram RD; Staub O; Bleich M; Schweda F; Loffing J
    J Physiol; 2016 Nov; 594(21):6319-6331. PubMed ID: 27457700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4.
    Castañeda-Bueno M; Arroyo JP; Zhang J; Puthumana J; Yarborough O; Shibata S; Rojas-Vega L; Gamba G; Rinehart J; Lifton RP
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):E879-E886. PubMed ID: 28096417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mechanisms of Na+ retention in obesity: phosphorylation of NKCC2 and regulation of SPAK/OSR1 by AMPK.
    Davies M; Fraser SA; Galic S; Choy SW; Katerelos M; Gleich K; Kemp BE; Mount PF; Power DA
    Am J Physiol Renal Physiol; 2014 Jul; 307(1):F96-F106. PubMed ID: 24808538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis.
    Rinehart J; Kahle KT; de Los Heros P; Vazquez N; Meade P; Wilson FH; Hebert SC; Gimenez I; Gamba G; Lifton RP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16777-82. PubMed ID: 16275913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulation of Na+Cl- cotransporter by with-no-lysine kinase 4.
    Argaiz ER; Gamba G
    Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):417-23. PubMed ID: 27322883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of NKCC2 activity by inhibitory SPAK isoforms: KS-SPAK is a more potent inhibitor than SPAK2.
    Park HJ; Curry JN; McCormick JA
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1687-96. PubMed ID: 24133122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension.
    Meor Azlan NF; Koeners MP; Zhang J
    Acta Pharm Sin B; 2021 May; 11(5):1117-1128. PubMed ID: 34094823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.